substance p has been researched along with Cardiac Remodeling, Ventricular in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (90.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbato, E; Bellis, A; Di Gioia, G; Mauro, C; Morisco, C; Sorriento, D; Trimarco, B | 1 |
| Levick, SP | 1 |
| Brower, GL; Janicki, JS; Levick, SP | 1 |
| Burckhardt, BB; Feickert, M | 1 |
| Dehlin, HM; Levick, SP; Manteufel, EJ; Monroe, AL; Reimer, MH | 1 |
| Dehlin, HM; Levick, SP | 1 |
| Fan, Z; Wang, H; Yang, C; Yang, J | 1 |
| Levick, SP; Meléndez, GC | 1 |
| Brower, GL; Janicki, JS; Levick, SP; Murray, DB | 1 |
| Janicki, JS; Law, BA; Levick, SP; Li, J; Meléndez, GC; Supowit, SC | 1 |
3 review(s) available for substance p and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
The Rationale of Neprilysin Inhibition in Prevention of Myocardial Ischemia-Reperfusion Injury during ST-Elevation Myocardial Infarction.
Topics: Adrenomedullin; Aminobutyrates; Angiotensin II; Animals; Apelin; Atrial Natriuretic Factor; Biphenyl Compounds; Bradykinin; Cardiotonic Agents; Drug Combinations; Gene Expression Regulation; Humans; Mice; Myocardial Reperfusion Injury; Neprilysin; ST Elevation Myocardial Infarction; Substance P; Survival Analysis; Tetrazoles; Valsartan; Ventricular Remodeling | 2020 |
Substance P in cardiovascular diseases - A bioanalytical review.
Topics: Animals; Cardiovascular Diseases; Clinical Chemistry Tests; Humans; Saliva; Substance P; Ventricular Remodeling | 2019 |
Substance P in heart failure: the good and the bad.
Topics: Animals; Heart; Heart Failure; Humans; Sensory Receptor Cells; Substance P; Ventricular Remodeling | 2014 |
7 other study(ies) available for substance p and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Understanding the Complex Roles of Substance P in the Diseased Heart.
Topics: Heart Diseases; Humans; Myocardium; Signal Transduction; Substance P; Ventricular Remodeling | 2018 |
Substance P-mediated cardiac mast cell activation: An in vitro study.
Topics: Animals; Cell Degranulation; Histamine; Histamine Release; Male; Mast Cells; Myocardium; PPAR gamma; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Substance P; Ventricular Remodeling | 2019 |
Substance P acting via the neurokinin-1 receptor regulates adverse myocardial remodeling in a rat model of hypertension.
Topics: Animals; Disease Models, Animal; Female; Gene Expression Regulation, Developmental; Heart Ventricles; Hypertension; Myocytes, Cardiac; Polymerase Chain Reaction; Pregnancy; Pregnancy, Animal; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Neurokinin-1; RNA, Messenger; Substance P; Ventricular Function, Left; Ventricular Remodeling | 2013 |
Relaxin: A novel therapy for acute heart failure.
Topics: Animals; Heart; Heart Failure; Humans; Substance P; Ventricular Remodeling | 2016 |
Targeting substance P and relaxin: A future combination therapy approach for heart failure?
Topics: Animals; Heart; Heart Failure; Humans; Substance P; Ventricular Remodeling | 2016 |
Sympathetic nervous system modulation of inflammation and remodeling in the hypertensive heart.
Topics: Analysis of Variance; Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Cytokines; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Hypertension; Inflammation Mediators; Male; Myocytes, Cardiac; Probability; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Substance P; Sympathectomy; Sympathetic Nervous System; Ventricular Remodeling | 2010 |
Substance P induces adverse myocardial remodelling via a mechanism involving cardiac mast cells.
Topics: Animals; Apoptosis; Cell Degranulation; Collagen; Disease Models, Animal; Heart Failure; In Situ Nick-End Labeling; Male; Mast Cells; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Neurokinin A; Neurokinin-1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Substance P; Time Factors; Tryptophan; Tumor Necrosis Factor-alpha; Ultrasonography; Ventricular Remodeling | 2011 |